A compact pellet injector is being built for the TJ-II stellarator. It is an upgraded version of the "pellet injector in a suitcase" developed at Oak Ridge National Laboratory and installed on the Madison Symmetric Torus where it continues to be used in many plasma experiments. The design aim is to provide maximum flexibility at minimal cost, while allowing for future upgrades. It is a four-barrel system equipped with a cryogenic refrigerator for in situ hydrogen pellet formation, a combined mechanical punch/propellant valve system, pellet diagnostics, and an injection line, destined for use as an active diagnostic and for fueling. In order to fulfill both objectives it will be sufficiently flexible to permit pellets, with diameters from 0.4 to 1 mm, to be fabricated and accelerated to velocities from 150 to approximately 1000 m s(-1).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1063/1.2955706 | DOI Listing |
Int J Impot Res
June 2024
Department of Urology, University of California, Irvine, CA, USA.
Despite a well-documented increase in both the prevalence of Testosterone Deficiency (TD) and prescription of testosterone replacement therapy (TRT), few studies have investigated the preferences of patients receiving TRT and factors associated with increased treatment satisfaction. To investigate the preferences of patients receiving TRT and factors associated with improved treatment satisfaction, an open survey was completed by 140 men receiving TRT at a single institution. Survey questions investigated demographics, symptom burden of TD, TRT regimen, treatment preferences, and treatment satisfaction.
View Article and Find Full Text PDFEur J Ophthalmol
May 2023
Unit of Macula. Department of Ophthalmology, Hospital de La Ribera, Alzira, Valencia, Spain.
Purpose: To show an alternative surgical technique for the introduction of the intravitreal fluocinolone acetonide (FAc) implant (Iluvien) into the vitreous cavity using a 23-gauge (G) trocar if it is retained during its implantation in the subconjunctival space.
Methods: We describe the surgical procedure performed to solve the complication: The FAc implant was extracted from the subconjunctival space using flat retinal forceps. A 23-G trocar was inserted 3,5 mm to the limbus.
Int J Ophthalmol
October 2020
Department of Ophthalmology, University Hospital of Heidelberg, Heidelberg 69120, Germany.
Aim: To evaluate major complications after intravitreal injection of dexamethasone implants (Ozurdex) and their clinical management.
Methods: In a retrospective observational study between 2014 and 2016 at two university hospitals, we reviewed the clinical records of 1241 consecutive macular edema patients treated with the dexamethasone implant, and separated severe adverse events in the injection procedure from those that were post-injection complications. We evaluated the cause and the outcomes in each case.
Eye (Lond)
February 2021
Royal Eye Infirmary, University hospitals of Plymouth NHS Trust, Derriford, Plymouth, PL6 8DH, UK.
Purpose: To assess the safety of nurse-led services of intravitreal injection of dexamethasone implant.
Methods: An audit of intravitreal injection of dexamethasone implant service in our unit revealed a significant delay in the delivery of injection from the time a clinical decision was made. The limiting factors were an inadequate number of injectors and limited capacity.
Ophthalmic Surg Lasers Imaging Retina
February 2019
Background And Objectives: Ozurdex intravitreal injection is performed via a patented injection device. However, there is a common misconception among ophthalmologists regarding the relation between the speed of applicator button depression and the speed of pellet injection.
Patients And Methods: Six dexamethasone intravitreal implants were injected into a calibrated ex vivo water bath.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!